Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights
Study Summary
This study is part of the development of a non-invasive lung cancer screening test which aim to identify early-stage lung cancer in patients at high risk for lung cancer.
Eligible Conditions
- Lung Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Performance
Trial Design
3Treatment groups
Experimental Treatment
Group I: USPSTF At Risk - Control CohortExperimental Treatment1 Intervention
Healthy subjects aged 50-80 years old with smoking history of at least 20 pack years.
Group II: Healthy Control CohortExperimental Treatment1 Intervention
Healthy subjects aged 20-80 years old which are non-smokers or with smoking history of less than 20 pack years.
Group III: Cases CohortExperimental Treatment1 Intervention
Subjects age 50-80 years old, with smoking history of at least 20 pack years with either (a) a high suspicion for lung cancer, who are planned to undergo biopsy or surgery to establish a definitive diagnosis after enrollment; or (b) confirmed primary lung cancer diagnosis, treatment naïve subjects.
Find a Location
Who is running the clinical trial?
Nucleix Ltd.Lead Sponsor
8 Previous Clinical Trials
8,581 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger